Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools

Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder

(2017) Chad A. Bousman et al.   Pharmacogenetics and Genomics

From Pharmacogenetics to Pharmacogenomics: The Way toward the Personalization of Antidepressant Treatment

(2017) Chiara Fabbri et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2D6andCYP2C19Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

(2015) JK Hicks et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation

(2015) Joel G. Winner et al.   CURRENT MEDICAL RESEARCH AND OPINION

Comparative Efficacy, Acceptability, and Tolerability of Augmentation Agents in Treatment-Resistant Depression

(2015) Xinyu Zhou et al.   JOURNAL OF CLINICAL PSYCHIATRY

Prediction of treatment outcomes in major depressive disorder

(2015) Boadie W Dunlop   Expert Review of Clinical Pharmacology

Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report

(2015) Ajeet B. Singh   Clinical Psychopharmacology and Neuroscience

Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions

(2014) Ursula Amstutz et al.   EPILEPSIA

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms

(2013) Gavin P. Reynolds et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing

(2013) S G Leckband et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting

(2013) Daniel K. Hall-Flavin et al.   Pharmacogenetics and Genomics

Consistency of drug–drug and gene–drug interaction information in US FDA-approved drug labels

(2013) Daniela J Conrado et al.   PHARMACOGENOMICS

Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression

(2013) J Winner et al.   Translational Psychiatry

Contribution of Common Genetic Variants to Antidepressant Response

(2012) Katherine E. Tansey et al.   BIOLOGICAL PSYCHIATRY

Randomized, Placebo-Controlled Trials of Antidepressants for Acute Major Depression: Thirty-Year Meta-Analytic Review

(2011) Juan Undurraga et al.   NEUROPSYCHOPHARMACOLOGY

Moderation of antidepressant response by the serotonin transporter gene

(2009) Patricia Huezo-Diaz et al.   BRITISH JOURNAL OF PSYCHIATRY

Treatment of SSRI-Resistant Depression: A Meta-Analysis Comparing Within- Versus Across-Class Switches

(2007) George I. Papakostas et al.   BIOLOGICAL PSYCHIATRY